1. Home
  2. FLYX.WS vs XCUR Comparison

FLYX.WS vs XCUR Comparison

Compare FLYX.WS & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLYX.WS

flyExclusive Inc. Redeemable warrants each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 per share

N/A

Current Price

$0.14

Market Cap

9.6M

ML Signal

N/A

Logo Exicure Inc.

XCUR

Exicure Inc.

SELL

Current Price

$1.11

Market Cap

9.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FLYX.WS
XCUR
Founded
N/A
2011
Country
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6M
9.2M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
FLYX.WS
XCUR
Price
$0.14
$1.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
★ 76.6K
Earning Date
N/A
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 83.37
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$44.02
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
N/A
$0.78
52 Week High
N/A
$9.48

Technical Indicators

Market Signals
Indicator
FLYX.WS
XCUR
Relative Strength Index (RSI) N/A 50.72
Support Level N/A $0.96
Resistance Level N/A $1.52
Average True Range (ATR) 0.00 0.13
MACD 0.00 0.02
Stochastic Oscillator 0.00 70.95

Price Performance

Historical Comparison
FLYX.WS
XCUR

About XCUR Exicure Inc.

Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.

Share on Social Networks: